Alto Neuroscience, Inc. Common Stock (ANRO)

CapEx to Revenue

0.00%

Quarterly · Period ending:

ANRO logo

ANRO CapEx to Revenue

Latest reported0.00%
ANRO Quarterly CapEx/Revenue (0.00% → 0.00%)
High-resolution chart · PNG

ANRO capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Alto Neuroscience, Inc. Common Stock CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.